Literatur
-
1
Lambert M V, Bird J M.
Obstructive sleep apnea following rapid weight gain secondary to treatment with vigabatrin (Sabril).
Seizure.
1997;
6
233-235
-
2
DeToledo J C, Toledo C, DeCerce J. et al .
Changes in body weight with chronic, high-dose gabapentin therapy.
Ther Drug Monit.
1997;
19
394-396
-
3
Isojärvi J L, Laatikainen T J, Knip M. et al .
Obesity and endocrine disorders in women taking valproate for epilepsy.
Ann Neurol.
1996;
39
579-584
-
4
Biton V, Mirza W, Montouris G. et al .
Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Neurology.
2001;
56
172-177
-
5
Luef G, Abraham I, Trinka E. et al .
Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Neurology.
2001;
57
565-566
-
6
Carmant L, Holmes G L, Sawyer S. et al .
Efficacy of felbamate in therapy for partial epilepsy in children.
J Pediatr.
1994;
125
481-486
-
7
Ben-Menachem E, Henriksen O, Dam M. et al .
Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
Epilepsia.
1996;
37
539-543
-
8
Biton V, Montouris G D, Ritter F. et al .
A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures.
Neurology.
1999;
52
1330-1337
-
9
Bernstein J G.
Psychotropic drug induced weight gain: mechanisms and management.
Clin Neuropharmacol.
1988;
11, Suppl 1
194-206
-
10
Stanton J M.
Weight gain associated with neuroleptic medication: a review.
Schizophr Bull.
1995;
21
463-472
-
11
Brady K T.
Weight gain associated with psychotropic drugs.
South Med J.
1989;
82
611-617
-
12
Silverstone T, Smith G, Goodall E.
Prevalence of obesity in patients receiving depot antipsychotics.
Br J Psychiat.
1988;
153
214-217
-
13
Flatt P R, Junti-Berggren L, Berggren P O. et al .
Effects of dietary inorganic trivalent chromium (Cr3+) on the development of glucose homeostasis in rats.
Diabet Metab.
1989;
15
93-97
-
14
Gomez R, Asnis N, Tannhauser S L. et al .
GABA agonists differentially modify blood glucose levels of diabetic rats.
Jpn J Pharmacol.
1999;
80
327-331
-
15
Shi Y, Kanaani J, Menard-Rose V, Ma Y H. et al .
Increased expression of GAD65 and GABA in pancreatic beta-cells impairs first-phase insulin secretion.
Am J Physiol Endocrinol Metab.
2000;
279
684-694
-
16
Boden G.
Free fatty acids, insulin resistance, and type 2 diabetes mellitus.
Proc Ass Am Physicians.
1999;
111
241-248
-
17
Grill V, Ovigstad E.
Fatty acids and insulin secretion.
Br J Nutr.
2000;
Suppl 1
79-84
-
18 Luef G, Abraham I, Trinka E. et al .Weight gain and increased postprandial serum insulin levels in epileptic patients with valproic acid therapy. Obesity Research 2001 in press
Dr. med. Gerhard Luef
Universitätsklinik für Neurologie
Anichstraße 35
6020 Innsbruck · Österreich
